PURPOSE–BUILT. PRECISION REPAIR. PRESERVES OPTIONS.
Tack Endovascular System®
Optimizing PTA with Precision Dissection Repair.
Tack Endovascular System®
Optimizing PTA with Precision Dissection Repair.
The Tack Endovascular System® is a first-of-its-kind minimal metal implant that effectively repairs above- and below-the-knee dissections. It is positioned to be the new standard of care for optimized balloon angioplasty for patients with peripheral artery disease (PAD) and critical limb ischemia (CLI).
TOBA II BTK 12-month results confirm the Tack Endovascular System® (4F, 1.5-4.5mm) is a durable, below-the-knee implant for post-PTA dissection repair that optimizes angioplasty to save limbs.
96.1%
12m K-M Target Limb Salvage in CLI patients (RC 4/5)*
*Post-hoc analysis, has not been reviewed by FDA.
About PAD and CLI
Facts and treatment options about peripheral artery disease and how it can progress to become critical limb ischemia, a dangerous and life-threatening condition
Why Dissections Matter
Dissections are often under diagnosed, underestimated and left untreated, but studies show that repairing dissections can dramatically improve outcomes1
Clinical Studies
Several ongoing clinical studies are underway to investigate the safety and efficacy of the Tack Endovascular System® in patients with PAD and CLI following balloon angioplasty
"Target limb salvage was excellent, we did not lose any claudicant limbs and very low limb loss in the CLTI group"
Dr. Patrick Geraghty presents the TOBA II BTK 12m study results
"These Tacks help heal patients wounds and ultimately decreases the Rutherford class so they don’t have pain, their wound heals, and they become mobile again"
Vascular News interview with Dr. George Adams following the late-breaking clinical trial presentation of the TOBA II BTK study results.
"Tack will augment an aggressive approach to BTK disease"
Dr. George Adams and Dr. Pat Geraghty discuss the TOBA II BTK study results, moderated by Dr. William Gray
"The actual 6-month K-M Tacked segment and lesion patency were impressive"
Dr. George Adams presents the TOBA II BTK pivotal study results
"…a total concurrent cost savings that supports Tack as the initial management for virtually any arterial dissection"
Dr. Michael R. Jaff discusses the cost effectiveness of repairing arterial dissections following angioplasty in femoropopliteal arteries
"Patients changed Rutherford categories more than 3 classes in this study"
Roundtable discussion of the TOBA III study results with Drs. Thomas Zeller, Marianne Brodmann, and Michael Lichtenberg
"High patency and CD-TLR rates in TOBA II position the Tack Endovascular System® to be a clinically important treatment option for dissection repair post-PTA"
Dr. William Gray presents the TOBA II pivotal study results
"TOBA II shows repairing dissections after angioplasty clearly augments outcomes for PAD patients"
Drs. William Gray and Thomas Zeller review the TOBA II clinical study results
"With focal dissection repair, the Tack Endovascular System® returns control to the operator”
Drs. Peter Schneider and Andrew Holden discuss the clinical impact of the Tack Endovascular System
"The Tack Endovascular System® is intended for very focal, minimal
footprint repair of dissections""
Dr. Peter Schneider 2017 LINC interview with Vascular News
For informational purposes only. You should always consult with your doctor when seeking medical advice or considering treatment.
References
- Bosiers M, Scheinert D, Hendriks JMH, et al. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. J Vasc Surg 2016; 64(1):109-16.
"Target limb salvage was excellent, we did not lose any claudicant limbs and very low limb loss in the CLTI group"
Dr. Patrick Geraghty presents the TOBA II BTK 12m study results
"These Tacks help heal patients wounds and ultimately decreases the Rutherford class so they don’t have pain, their wound heals, and they become mobile again"
Vascular News interview with Dr. George Adams following the late-breaking clinical trial presentation of the TOBA II BTK study results.
"Tack will augment an aggressive approach to BTK disease"
Dr. George Adams and Dr. Pat Geraghty discuss the TOBA II BTK study results, moderated by Dr. William Gray
"The actual 6-month K-M Tacked segment and lesion patency were impressive"
Dr. George Adams presents the TOBA II BTK pivotal study results
"…a total concurrent cost savings that supports Tack as the initial management for virtually any arterial dissection"
Dr. Michael R. Jaff discusses the cost effectiveness of repairing arterial dissections following angioplasty in femoropopliteal arteries
"Patients changed Rutherford categories more than 3 classes in this study"
Roundtable discussion of the TOBA III study results with Drs. Thomas Zeller, Marianne Brodmann, and Michael Lichtenberg
"High patency and CD-TLR rates in
TOBA II position the Tack® System to
be a clinically important treatment
option for dissection repair post-PTA"
Dr. William Gray presents the TOBA II pivotal study results
"TOBA II shows repairing dissections after angioplasty clearly augments outcomes for PAD patients"
Drs. William Gray and Thomas Zeller review the TOBA II clinical study results
"With focal dissection repair, the
Tack Endovascular System®returns
control to the operator”
Drs. Peter Schneider and Andrew Holden discuss the clinical impact of the Tack Endovascular System
Dr. Peter Schneider 2017 LINC interview with Vascular News
For informational purposes only. You should always consult with your doctor when seeking medical advice or considering treatment.
References
- Bosiers M, Scheinert D, Hendriks JMH, et al. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. J Vasc Surg 2016; 64(1):109-16.